Review
. 2003:53 Suppl 3:S110-8; discussion S118-9.
doi: 10.1002/ana.10480.
Imaging end points for monitoring neuroprotection in Parkinson's disease
Affiliations
- PMID: 12666103
- DOI: 10.1002/ana.10480
Item in Clipboard
Review
Imaging end points for monitoring neuroprotection in Parkinson's disease
Ann Neurol.
2003.
Abstract
In this review, the potential role of positron emission tomography and single-photon emission computed tomography as biological markers for following the progression of Parkinson's disease (PD) is discussed, and their value for assessing the efficacy of putative neuroprotective agents in PD is considered. It is concluded that functional imaging provides a valuable adjunct to clinical assessment when judging the efficacy of neuroprotective approaches to PD.
Similar articles
-
Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies.Ann Neurol. 2003;53 Suppl 3:S160-6; discussion S166-9. doi: 10.1002/ana.10486. Ann Neurol. 2003. PMID: 12666107 Review. No abstract available.
-
A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?Mov Disord. 2004 May;19(5):491-8. doi: 10.1002/mds.20057. Mov Disord. 2004. PMID: 15133811 Review.
-
Neuroprotection in Parkinson's disease: clinical trials.Ann Neurol. 2003;53 Suppl 3:S87-97; discussion S97-9. doi: 10.1002/ana.10488. Ann Neurol. 2003. PMID: 12666101 Review.
-
Where do we stand on neuroprotection? Where do we go from here?Mov Disord. 1998;13 Suppl 1:46-8. Mov Disord. 1998. PMID: 9613718 Review.
-
Monitoring neuroprotection and restorative therapies in Parkinson's disease with PET.J Neural Transm Suppl. 2000;(60):125-37. doi: 10.1007/978-3-7091-6301-6_8. J Neural Transm Suppl. 2000. PMID: 11205135 Review.
Cited by
-
Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice.J Neurosci. 2007 Aug 15;27(33):8816-25. doi: 10.1523/JNEUROSCI.1067-07.2007. J Neurosci. 2007. PMID: 17699663 Free PMC article.
-
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.Neuroimage. 2010 Apr 1;50(2):524-531. doi: 10.1016/j.neuroimage.2009.12.058. Epub 2009 Dec 23. Neuroimage. 2010. PMID: 20034580 Free PMC article.
-
Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1119-27. doi: 10.1007/s00259-004-1480-6. Epub 2004 Apr 3. Eur J Nucl Med Mol Imaging. 2004. PMID: 15064872 Clinical Trial.
-
Applications of positron emission tomography (PET) in neurology.J Neurol Neurosurg Psychiatry. 2004 May;75(5):669-76. doi: 10.1136/jnnp.2003.028175. J Neurol Neurosurg Psychiatry. 2004. PMID: 15090557 Free PMC article. Review.
-
Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates.Neurotoxicology. 2011 Mar;32(2):215-26. doi: 10.1016/j.neuro.2010.11.003. Epub 2010 Nov 26. Neurotoxicology. 2011. PMID: 21112353 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
